398 related articles for article (PubMed ID: 24237641)
1. A review of FDA-approved treatment options in bipolar depression.
McIntyre RS; Cha DS; Kim RD; Mansur RB
CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
[TBL] [Abstract][Full Text] [Related]
2. Balancing benefits and harms of treatments for acute bipolar depression.
Ketter TA; Miller S; Dell'Osso B; Calabrese JR; Frye MA; Citrome L
J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Taylor DM; Cornelius V; Smith L; Young AH
Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
[TBL] [Abstract][Full Text] [Related]
4. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
5. Acute and maintenance treatments for bipolar depression.
Ketter TA
J Clin Psychiatry; 2014 Apr; 75(4):e10. PubMed ID: 24813411
[TBL] [Abstract][Full Text] [Related]
6. Current landscape, unmet needs, and future directions for treatment of bipolar depression.
Frye MA; Prieto ML; Bobo WV; Kung S; Veldic M; Alarcon RD; Moore KM; Choi DS; Biernacka JM; Tye SJ
J Affect Disord; 2014 Dec; 169 Suppl 1():S17-23. PubMed ID: 25533910
[TBL] [Abstract][Full Text] [Related]
7. Newer treatment studies for bipolar depression.
Gao K; Calabrese JR
Bipolar Disord; 2005; 7 Suppl 5():13-23. PubMed ID: 16225556
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L; Ketter TA; Cucchiaro J; Loebel A
J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
[TBL] [Abstract][Full Text] [Related]
9. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
Citrome L
Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Lazarus A
Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
[TBL] [Abstract][Full Text] [Related]
12. Second-Generation Antipsychotics in Management of Acute Pediatric Bipolar Depression: A Systematic Review and Meta-analysis.
Patel RS; Veluri N; Patel J; Patel R; Machado T; Diler R
J Child Adolesc Psychopharmacol; 2021 Oct; 31(8):521-530. PubMed ID: 34665020
[No Abstract] [Full Text] [Related]
13. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of treatments for bipolar depression.
Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ
J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice. Bipolar disorder--a focus on depression.
Frye MA
N Engl J Med; 2011 Jan; 364(1):51-9. PubMed ID: 21208108
[No Abstract] [Full Text] [Related]
16. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
17. Pros and cons of approved therapies for bipolar depression and ongoing unmet needs.
McElroy SL
J Clin Psychiatry; 2014 Oct; 75(10):e26. PubMed ID: 25373131
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
20. An update on the treatment of bipolar depression.
Azorin JM; Kaladjian A
Expert Opin Pharmacother; 2009 Feb; 10(2):161-72. PubMed ID: 19236191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
